Updates are available Correction dated 2022-05-31

Article History

Received: 4 January 2022

Accepted: 28 March 2022

First Online: 22 April 2022

Change Date: 31 May 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00270-022-03171-6

Declarations

:

: FEB is a co-founder of Claripacs, LLC. He received research support (investigator-initiated) from GE Healthcare. He received research grants from the US Department of Defense, Thompson Family Foundation, and Brockman Medical Research Foundation. He received research supplies (investigator-initiated) from Bayer, Steba Biotech, and Terumo. He received a research grant and speaker fees from Society of Interventional Oncology, which were sponsored by Guerbet. He attended research meetings sponsored by Guerbet. He is an investor in Labdoor, Qventus, CloudMedx, Notable Labs, and Xgenomes. He is the inventor and assignee on US patent 8233586, and is an inventor on US provisional patent applications 62/754,139 and 62/817,116. EZ received research grants from: Society of Interventional Radiology, Radiological Society of North America, North American Neuroendocrine Tumor Society, American Association for Cancer Research, Druckenmiller Foundation, Memorial Sloan Kettering Cancer Center, Ethicon, and Novartis. CS received grants from NIH/NCI, Boston Scientific/BTG, Ethicon, and SIRTEX. He received personal fees from Boston Scientific/BTG, Terumo, Varian, Ethicon, and SIRTEX. HY is an advisory board member of BD Medical.